Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Enlivex Ltd. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- 0 vs. Q1 2023
- Shares held
- 302.5K
- −40.8K (−11.9%) vs. Q1 2023
- Total value
- $795.1K
- −$442.9K (−35.8%) vs. Q1 2023
- New holders
- 1
- 3 more added
- Sold out
- 1
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Compagnie Lombard Odier SCmA | 65,000 | $171.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 56,689 | $149.0K | 0.00% | +2,000+3.7% | Added |
| Morgan Stanley | 43,851 | $115.2K | 0.00% | +3,692+9.2% | Added |
| Citadel Advisors LLC | 38,615 | $101.6K | 0.00% | −10,849−21.9% | Reduced |
| UBS Group AG | 17,810 | $46.8K | 0.00% | −13,643−43.4% | Reduced |
| Susquehanna International Group Ltd. | 15,091 | $39.7K | 0.03% | −2,775−15.5% | Reduced |
| Edmond de Rothschild Holding S.A. | 13,000 | $34.2K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 12,675 | $33.0K | 0.00% | −38−0.3% | Reduced |
| Goldman Sachs Group Inc | 11,297 | $29.7K | 0.00% | −7,573−40.1% | Reduced |
| Geode Capital Management, LLC | 10,420 | $27.4K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 8,882 | $23.3K | 0.00% | −1,814−17.0% | Reduced |
| Steward Partners Investment Advisory, LLC | 3,000 | $7.88K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,379 | $6.26K | 0.00% | +2,307+3,204.2% | Added |
| Group One Trading, L.P. | 1,100 | $2.89K | 0.00% | −12,399−91.9% | Reduced |
| Barclays PLC | 1,000 | $2.63K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 838 | $2.20K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 400 | $1.05K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 290 | $762 | 0.00% | +290 | New |
| Red Tortoise LLC | 150 | $394 | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |